Akihiro Asai Selected Research

Oral Administration

10/2021

Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiro Asai Research Topics

Disease

9	Neoplasms (Cancer) 05/2019 - 12/2014
6	Cholestasis 04/2024 - 01/2019
4	Urinary Bladder Neoplasms (Bladder Cancer) 09/2022 - 12/2014
4	Carcinogenesis 04/2022 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 01/2015
4	Neoplasm Metastasis (Metastasis) 01/2018 - 11/2013
3	Necrosis 04/2024 - 08/2021
3	Biliary Atresia 08/2023 - 01/2019
2	Glycogen Storage Disease Type IV (Andersen's Disease) 06/2024 - 01/2023
2	Insulin Resistance 03/2014 - 05/2006
1	Rare Diseases (Rare Disease) 06/2024
1	Glycogen Storage Disease (Glycogenosis) 06/2024
1	Portal Hypertension 12/2023
1	Liver Failure 04/2022
1	Cysts 01/2022
1	Liver Diseases (Liver Disease) 01/2021
1	Hyperammonemia 01/2021
1	Ornithine Carbamoyltransferase Deficiency Disease 01/2021
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 05/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2018
1	Ureteral Obstruction 02/2018
1	Fever (Fevers) 02/2018
1	Pyelonephritis 02/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Neonatal hemochromatosis 11/2016
1	Overactive Urinary Bladder (Overactive Bladder) 07/2016
1	Lower Urinary Tract Symptoms 07/2016
1	Pain (Aches) 10/2015
1	Fatigue 10/2015
1	Extramammary Paget Disease (Paget Disease, Extramammary) 02/2015
1	Disease Progression 12/2014
1	Obesity 03/2014
1	Non-alcoholic Fatty Liver Disease 03/2014
1	Inflammation (Inflammations) 03/2014
1	Glucose Intolerance 03/2014
1	Ischemia 08/2007
1	Muscular Dystrophies (Muscular Dystrophy) 08/2007

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 06/2024 - 05/2006
2	1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA 06/2024 - 01/2023
2	Bile Acids and Salts (Bile Acids)IBA 04/2024 - 01/2021
2	Transaminases (Aminotransferases)IBA 04/2024 - 01/2021
2	BilirubinIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2017
2	AntigensIBA 01/2017 - 01/2016
2	Formaldehyde (Formol)FDA Link 12/2014 - 11/2013
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 12/2023
1	Zonula Occludens-2 ProteinIBA 04/2022
1	Dinoprostone (PGE2)FDA Link 10/2021
1	ProstaglandinsIBA 10/2021
1	Hyaluronic Acid (Hyaluronan)IBA 08/2021
1	Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA 01/2021
1	Bosentan (Tracleer)FDA Link 01/2021
1	AntioxidantsIBA 05/2019
1	Matrix Metalloproteinases (MMPs)IBA 05/2019
1	4N1K peptideIBA 05/2019
1	Thrombospondin 1IBA 05/2019
1	Sunitinib (Sutent)FDA Link 06/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Guanosine Triphosphate (GTP)IBA 01/2017
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017
1	PolyphenolsIBA 01/2017
1	AndrogensIBA 01/2017
1	TeaIBA 01/2017
1	Vascular Endothelial Growth Factor CIBA 01/2017
1	IronIBA 11/2016
1	mirabegronIBA 07/2016
1	Hormones (Hormone)IBA 01/2016
1	Vascular Endothelial Growth FactorsIBA 01/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016
1	Gemcitabine FDA Link 10/2015
1	Cisplatin (Platino)FDA LinkGeneric 10/2015
1	Sorafenib (BAY 43-9006)FDA Link 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2014
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 12/2014
1	Vascular Endothelial Growth Factor DIBA 12/2014
1	Heme Oxygenase-1IBA 12/2014
1	CarbohydratesIBA 03/2014
1	Triglycerides (Triacylglycerol)IBA 03/2014
1	Blood Glucose (Blood Sugar)IBA 03/2014
1	Insulin (Novolin)FDA Link 03/2014
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 08/2007

Therapy/Procedure

9	Therapeutics 08/2023 - 08/2007
2	Liver Transplantation 12/2023 - 01/2021
2	Hepatic Portoenterostomy 08/2023 - 01/2022
2	Aftercare (After-Treatment) 07/2016 - 10/2015
2	Prostatectomy (Retropubic Prostatectomy) 01/2016 - 01/2015
1	Intravesical Administration 09/2022
1	Transurethral Resection of Bladder 09/2022
1	Operative Surgical Procedures 01/2022
1	Jejunostomy 01/2022
1	Oral Administration 10/2021
1	Stents 02/2018
1	Castration 01/2016
1	Urinary Diversion (Ileal Conduit) 02/2015
1	Neoadjuvant Therapy 01/2015